Share：
Share this content in WeChat
X
[Chinese][PDF]83875
• Review •
MRI research progress of encephalopathy in patients with type 2 diabetes
LIU Wen  LIU Sheng  WANG Wei  LIU Hua-sheng 

DOI:10.3969/j.issn.1674-8034.2015.10.014.


[Abstract] Type 2 diabetes mellitus is a kind of common chronic glycometabolism disorder. It can cause multiple terminal target organs damage, and diabetes related cognitive dysfunction has become a focus of attention for the researchers, but its pathogenesis remains unclear. Magnetic resonance imaging (MRI) has become an important means to study the biological basis of brain damage in vivo. This review will discuss the brain MRI imaging abnormalities about type 2 diabetes, and expects to provide some basis for clarifying the pathogenesis of type 2 diabetes encephalopathy and its clinical diagnosis and treatment.
[Keywords] Type 2 diabetes mellitus；Cognitive dysfunction；White matter hyperintens-ities；Magnetic resonance imaging；Magnetic resonance spectrum

LIU Wen Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha 410013, China

LIU Sheng* Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha 410013, China

WANG Wei* Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha 410013, China

LIU Hua-sheng Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha 410013, China

*Correspondence to: Liu S, E-mail: liushe0@qq.com; Wang W, E-mail: cjr.wangwei@vip.163.com

Conflicts of interest   None.

Received  2015-08-16
Accepted  2015-09-15
DOI: 10.3969/j.issn.1674-8034.2015.10.014
DOI:10.3969/j.issn.1674-8034.2015.10.014.

[1]
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice, 2010, 87(1): 4-14.
[2]
张倩，伍建林.多模态功能MRI对糖尿病脑病的研究.磁共振成像, 2015, 6(1): 58-61.
[3]
Biessels GJ. Sweet memories: 20 years of progress in research on cognitive functioning in diabetes. Eur J Pharmacol, 2013, 719(1-3): 153-160.
[4]
Moran C, Phan TG, Chen J, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care, 2014, 36(12): 4036-4042.
[5]
Falvey CM, Rosano C, Simonsick EM, et al. Macro-and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care, 2013, 36(3): 677-682.
[6]
Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage, 2012, 59(2): 1098-1105.
[7]
Miles WR, Root HF. Psychologic tests applied in diabetic patients. Arch Intern Med, 1922, 30(6): 767-777.
[8]
Reijmer YD, van den Berg E, Ruis C, et al. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev, 2010, 26(7): 507-519.
[9]
van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia, 2010, 53 (1): 58-65.
[10]
Ryan JP, Fine DF, Rosano C. Type 2 Diabetes and Cognitive Impairment: Contributions from Neuroimaging. J Geriatr Psychiatry Neurol, 2014, 27(1): 47-55.
[11]
Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci, 2015 DOI: .[ DOI: ].
[12]
Roy S, Kim N, Desai A, et al. Cognitive Function and Control of Type 2 Diabetes Mellitus in Young Adults. N Am J Med Sci, 2015, 7(5): 220-226.
[13]
Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction inolder subjects with diabetes mellitus: impact on diabetes selfmanagement and use of care services. All Wales Research intoElderly (AWARE) Study. Diabetes Res Clin Pract, 2000, 50(3): 203-212.
[14]
Gregg EW, Brown AM. Cognitive and physical disabilities and aging-related complications of diabetes. Clin Diabetes, 2003, 21(3): 113-118.
[15]
Roberts RO, Knopman DS, Przybelski SA, et al. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology, 2014, 82(13): 1132-1141.
[16]
Brundel M, van den Heuvel M, de Bresser J, et al. Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci, 2010, 299(1-2): 126-130.
[17]
Kooistra M, Geerlings MI, Mali WP, et al. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study. J Neurol Sci, 2013, 332(1-2): 69-74.
[18]
van Elderen SG, de Roos A, de Craen AJ, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology, 2010, 75 (11): 997-1002.
[19]
Espeland MA, Bryan RN, Goveas JS, et al. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women’s Health Initiative Magnetic Resonance Imaging studies. Diabetes Care, 2013, 36(1): 90-97.
[20]
Hayashi K, Kurioka S, Yamaguchi T, et al. Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Res Clin Pract, 2011, 94(2): 180-185.
[21]
van Harten B, Oosterman JM, PottervanLoon BJ, et al. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol, 2007, 57(2): 70-74.
[22]
Jongen C, vander Grond J, Kappelle LJ, et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia, 2007, 50(7): 1509-1516.
[23]
刘桂锋，姚铭，陈琰. MRI血管及灌注成像对糖尿病患者脑血管病变的应用研究.磁共振成像, 2013, 4(5): 321-324.
[24]
Saczynski JS, Siggurdsson S, Jonsson PV, et al. Glycemic status and brain injury in older in dividuals:the agegene/environment susceptibility-Reykjavik study. Diabetes Care, 2009, 32(9): 1608-1613.
[25]
Knopman DS, Mosley TH, Catellier DJ, et al. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology, 2005, 65(6): 876-881.
[26]
Reijmer YD, Brundel M, de Bresser J, et al. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes:a diffusion tensor imaging study. Diabetes Care, 2013, 36(1): 137-144.
[27]
Musen G, Jacobson AM, Bolo NR, et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes, 2012, 61(9): 2375-2379.
[28]
Zhou H, Lu W, Shi Y, et al. Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci Lett, 2010, 473(1): 5-10.
[29]
Hoogenboom WS, Marder TJ, Flores VL, et al. Cerebral White Matter Integrity and Resting-State Functional Connectivity in Middle-aged Patients With Type 2 Diabetes Early detection. Diabetes, 2014, 63(2): 728-738.
[30]
Margulies DS, Böttger J, Long X, et al. Resting developments: a review of fMRI post-processing methodologies for spontaneous brain activity. MAGMA, 2010, 23(5-6): 289-307.
[31]
An L, Cao QJ, Sui MQ, et al. Local synchronization and amplitude of thefluctuation of spontaneous brain activity in attention-deficit/hyperactivitydisorder: a resting-state fMRI study. Neurosci Bull, 2013, 29(5): 603-613.
[32]
Xia W, Wang S, Sun Z, et al. Altered baseline brain activity in type 2 diabetes:a resting-state fMRI study. Psychoneuroendocrinology, 2014, 38(11): 2493-2501.
[33]
Cui Y, Jiao Y, Chen YC, et al. Altered spontaneous brain activity in type 2 diabetes: a resting-state functional MRI study. Diabetes, 2014, 63(2): 749-760.
[34]
刘代洪，段姗姗，张久权,等. 2型糖尿病伴轻度认知功能障碍患者脑静息态功能MRI研究.磁共振成像, 2015, 6(3): 161-167.
[35]
Biessels GJ, Braun KP, de Graaf RA, et al. Cerebral metabolism in streptozotocin-diabetic rats: an in vivo magnetic resonance spectroscopy study. Diabetologia, 2001, 44(3): 346-353.
[36]
Sinha S, Ekka M, Sharma U, et al. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Research Notes, 2014, 7: 41.
[37]
Lin Y, Zhou J, Sha L, et al. Metabolite differences in the lenticular nucleus in type 2 diabetes mellitus shown by proton MR spectroscopy. AJNR Am J Neuroradiol, 2013, 34(9): 1692-1696.
[38]
Sahin I, Alkan A, Keskin L, et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications, 2008, 22(4): 254-260.
[39]
Modi S, Bhattacharya M, Sekhri T, et al. Assessment of the metabolic profile in type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy. Magn Reson Imaging, 2008, 26(3): 420-425.

PREV Semi-quantitative and quantitative parametric analysis of 3.0 T dynamic contrast-enhanced magnetic resonance imaging in diagnosing tumors of ovary
NEXT The research status and application prospect of magnetic resonance spectrum in alcohol addicts
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn